Results summary | View all lists in L2L MDB | View all genes in C08E.profile.u50 |
Upregulated by DAC treatment in at least one of four pancreatic cancer cell lines, but not in normal (HPDE) cells enrichment: 3.71-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
210538_S_AT | BIRC3 | G | S | ![]() |
![]() |
baculoviral IAP repeat-containing 3 | |||||||
207528_S_AT | SLC7A11 | T | P | ![]() |
![]() |
solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | |||||||
202637_S_AT | ICAM1 | C | ![]() |
![]() |
intercellular adhesion molecule 1 (CD54), human rhinovirus receptor | ||||||||
215501_S_AT | DUSP10 | X | P | S | ![]() |
![]() |
dual specificity phosphatase 10 | ||||||
201925_S_AT | CD55 | X | P | ![]() |
![]() |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) | |||||||
208926_AT | NEU1 | ![]() |
![]() |
sialidase 1 (lysosomal sialidase) |